A robust core business, superb free cash flow margins, and industry-leading earnings-per-share growth power a bullish case. More upside ahead for DexCom?
Expanding free cash flow margins, rising monthly active platform users, and an accelerated push into autonomous vehicles hail bullish catalysts. Should you buy the correction in Uber?